References
- Levy E, Haltia M, Fernandez-Madrid I, et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med. 1990;172(6):1865–1867.
- Kwiatkowski DJ, Westbrook CA, Bruns GA, et al. Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet. 1988;42(4):565–572.
- de la Chapelle A, Tolvanen R, Boysen G, et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet. 1992;2(2):157–160.
- Chen CD, Huff ME, Matteson J, et al. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. EMBO J. 2001;20(22):6277–6287.
- Page LJ, Suk JY, Huff ME, et al. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J. 2005;24(23):4124–4132.
- Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report on three cases. Acta Pathol Microbiol Scand A. 1971;79(5):432–440.
- Kiuru-Enari S, Keski-Oja J, Haltia M. Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol. 2005;152(2):250–257.
- Koskelainen S, Pihlamaa T, Suominen S, et al. Gelsolin amyloid angiopathy causes severe disruption of the arterial wall. APMIS. 2016;124(8):639–648.
- Sethi S, Theis JD, Quint P, et al. Renal amyloidosis associated with a novel sequence variant of gelsolin. Am J Kidney Dis. 2013;61(1):161–166.
- Efebera YA, Sturm A, Baack EC, et al. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. Amyloid. 2014;21(2):110–112.
- Oregel KZ, Shouse GP, Oster C, et al. Atypical presentation of gelsolin amyloidosis in a man of African descent with a novel mutation in the gelsolin gene. Am J Case Rep. 2018;19:374–381.
- Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969;1(4):314–324.
- Mustonen T, Schmidt EK, Valori M, et al. Common origin of the gelsolin gene variant in 62 Finnish AGel amyloidosis families. Eur J Hum Genet. 2018;26(1):117–123.
- Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5(1):55–66.
- Kiuru-Enari S, Haltia M. Hereditary gelsolin amyloidosis. Handb Clin Neurol. 2013;115:659–681.
- Maramattom BV, Chickabasaviah YT. A new Indian family affected by gelsolin amyloidosis. Neurol India. 2013;61(6):673–675.
- Gonzalez-Rodriguez J, Ramirez-Miranda A, Hernandez-Da Mota SE, et al. TGFBI, CHST6, and GSN gene analysis in Mexican patients with stromal corneal dystrophies. Graefes Arch Clin Exp Ophthalmol. 2014;252(8):1267–1272.
- Alabdali M, Barnett C, Abraham A, et al. Gelsolin familial amyloidosis peripheral neuropathy in Canada: a case report. Can J Neurol Sci. 2015;42(5):353–355.
- Park KJ, Park JH, Park JH, et al. The first Korean family with hereditary gelsolin amyloidosis caused by p.D214Y mutation in the GSN gene. Ann Lab Med. 2016;36(3):259–262.
- Lucero Saa F, Cremona FA, Minguez NX, et al. The first Argentinian family with familial amyloidosis of the Finnish type. Case Rep Ophthalmol. 2017;8(2):446–451.
- Schmidt EK, Atula S, Tanskanen M, et al. Causes of death and life span in Finnish gelsolin amyloidosis. Ann Med. 2016;48(5):352–358.
- Pihlamaa T, Rautio J, Kiuru-Enari S, et al. Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg. 2011;127(6):2342–2351.
- Maury CP, Kere J, Tolvanen R, et al. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics. 1992;13(3):902–903.
- Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci. 2002;115(Pt 14):2817–2828.
- Baldwin AK, Simpson A, Steer R, et al. Elastic fibres in health and disease. Expert Rev Mol Med. 2013;15:e8.
- Baud S, Duca L, Bochicchio B, et al. Elastin peptides in aging and pathological conditions. Biomol Concepts. 2013;4(1):65–76.
- Werb Z, Banda MJ, McKerrow JH, et al. Elastases and elastin degradation. J Invest Dermatol. 1982;79(s1):154s–159s.
- Kunecki M, Nawrocka A. Elastin-laminin receptor and abdominal aortic aneurysms. New subject to study? A review. Pathol Biol (Paris). 2001;49(4):333–338.
- Budd RC, Firestein GS, Gabriel SE, et al. Kelley's textbook of rheumatology. 9th ed. Philadelphia (PA): Elsevier/Saunders; 2013.
- Mecham RP, Broekelmann TJ, Fliszar CJ, et al. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem. 1997;272(29):18071–18076.
- Akhurst RJ, Hata A. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov. 2012;11(10):790–811.
- Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol. 1990;136(6):1223–1228.
- Pasquali-Ronchetti I, Baccarani-Contri M. Elastic fiber during development and aging. Microsc Res Tech. 1997;38(4):428–435.
- Braverman IM, Fonferko E. Studies in cutaneous aging: I. The elastic fiber network. J Invest Dermatol. 1982;78(5):434–443.
- Kwak HB. Aging, exercise, and extracellular matrix in the heart. J Exerc Rehabil. 2013;9(3):338–347.
- Alvira CM, Guignabert C, Kim YM, et al. Inhibition of transforming growth factor beta worsens elastin degradation in a murine model of Kawasaki disease. Am J Pathol. 2011;178(3):1210–1220.
- Sherratt MJ. Tissue elasticity and the ageing elastic fibre. Age (Dordr). 2009;31(4):305–325.
- Robert L, Robert AM, Fulop T. Rapid increase in human life expectancy: will it soon be limited by the aging of elastin? Biogerontology. 2008;9(2):119–133.
- Winkelmann RK, Peters MS, Venencie PY. Amyloid elastosis. A new cutaneous and systemic pattern of amyloidosis. Arch Dermatol. 1985;121(4):498–502.
- Sepp N, Pichler E, Breathnach SM, et al. Amyloid elastosis: analysis of the role of amyloid P component. J Am Acad Dermatol. 1990;22(1):27–34.
- Vecchietti G, Masouye I, Salomon D, et al. An unusual form of primary systemic amyloidosis: amyloid elastosis: report of a case treated by haematopoietic cell transplantation. Br J Dermatol. 2003;148(1):154–159.
- Bocquier B, D’Incan M, Joubert J, et al. Amyloid elastosis: a new case studied extensively by electron microscopy and immunohistochemistry. Br J Dermatol. 2008;158(4):858–860.
- Santos-Briz A, Canueto J, Antunez P, et al. Primary cutaneous localized amyloid elastosis. Am J Dermatopathol. 2010;32(1):86–90.
- Marchand A, Levaltier X, Croue A, et al. Cutaneous amyloid elastosis revealing multiple myeloma with systemic amyloidosis. Acta Derm Venerol. 2013;93(2):204–205.
- Tian J, Shi J, Mann DM. Cerebral amyloid angiopathy and dementia. Panminerva Med. 2004;46(4):253–264.
- Larsson A, Peng S, Persson H, et al. Lactadherin binds to elastin – a starting point for medin amyloid formation? Amyloid. 2006;13(2):78–85.
- Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130(2–3):88–98.
- Xue WF, Homans SW, Radford SE. Amyloid fibril length distribution quantified by atomic force microscopy single-particle image analysis. Protein Eng Des Sel. 2009;22(8):489–496.
- Bochicchio B, Pepe A, Tamburro A. Elastic fibers and amyloid deposition in vascular tissue. Future Neurol. 2007;2(5):523–536.
- Bochicchio B, Pepe A, Delaunay F, et al. Amyloidogenesis of proteolytic fragments of human elastin. RSC Adv. 2013;3(32):13273–13285.
- Hornebeck W, Emonard H. The cell–elastin–elastase(s) interacting triade directs elastolysis. Front Biosci. 2011;16(1):707–722.
- Suwabe H, Serizawa A, Kajiwara H, et al. Degenerative processes of elastic fibers in sun-protected and sun-exposed skin: immunoelectron microscopic observation of elastin, fibrillin-1, amyloid P component, lysozyme and alpha1-antitrypsin. Pathol Int. 1999;49(5):391–402.
- Tanaka K, Essick EE, Doros G, et al. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis. J Am Heart Assoc. 2013;2(2):e005868.
- Horstmann S, Budig L, Gardner H, et al. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int Psychogeriatr. 2010;22(6):966–972.
- Massam-Wu T, Chiu M, Choudhury R, et al. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J Cell Sci. 2010;123(17):3006–3018.
- Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18(7):816–827.